https://www.selleckchem.com/products/r428.html
82-0.94), C-reactive protein (pooled HR 1.44, 95% CI 1.26-1.66), De Ritis ratio (pooled HR 2.18, 95% CI 1.37-3.48), white blood cell count (pooled HR 1.05, 95% CI 1.02-1.07), and albumin-globulin ratio (pooled HR 0.26, 95% CI 0.14-0.48). Several pretreatment laboratory abnormalities in patients with urothelial carcinoma of the bladder were associated with cancer-specific mortality. Therefore, it might be useful to incorporate such hematologic biomarkers into prognostic tools for urothelial carcinoma of the bladder. However, given the study
Like
Comment
Share
